Neuroprotective Effect of Maresin-1 in Rotenone-Induced Parkinson’s Disease in Rats: The Putative Role of the JAK/STAT Pathway
2025

Maresin-1 Protects Against Parkinson's Disease in Rats

Sample size: 30 publication 10 minutes Evidence: moderate

Author Information

Author(s): Khodir Suzan A., Sweed Eman M., Faried Manar A., Abo Elkhair Doaa M., Khalil Marwa M., Afifi Khaled Hatem, El Agamy Dalia Fathy

Primary Institution: Menoufia University, Egypt

Hypothesis

The study aimed to evaluate the protective effects of Maresin-1 in rotenone-induced Parkinson's disease and its association with the JAK/STAT signaling pathway.

Conclusion

Maresin-1 effectively alleviated motor impairments and biochemical alterations induced by rotenone in rats, suggesting its potential as a neuroprotective agent.

Supporting Evidence

  • Maresin-1 treatment improved motor function in rats with Parkinson's disease.
  • Inflammatory markers were significantly reduced in the ROT + MaR1 group compared to the ROT group.
  • Histopathological analysis showed less neuronal degeneration in the ROT + MaR1 group.
  • Biochemical evaluations indicated increased levels of neurotrophic factors in the ROT + MaR1 group.

Takeaway

Maresin-1 is like a superhero for rats with Parkinson's disease, helping them move better and feel less sick after being exposed to a harmful chemical.

Methodology

Thirty male Wistar rats were divided into control, ROT-treated, and ROT + MaR1-treated groups, undergoing various motor behavioral tests and biochemical evaluations.

Limitations

The study did not include a group treated with only Maresin-1 to compare its effects independently.

Participant Demographics

Thirty male Wistar rats, aged 8-12 weeks, weighing 200-220 g.

Statistical Information

P-Value

p<0.05

Confidence Interval

95%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s11064-024-04282-x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication